Crucell to Present at 2003 UBS Global Life Sciences Conference
Leiden, The Netherlands, September 19, 2003 - Dutch biotechnology company, Crucell N.V. (Euronext, NASDAQ: CRXL) today announced that it is presenting at the 2003 UBS Global Life Sciences Conference being held September 22-25, 2003 in The Plaza Hotel, New York City. Crucell's CEO, Dinko Valerio, will be presenting on Thursday, September 25, 2003 at 4:00 p.m.

Crucell (Euronext, NASDAQ: CRXL) and DSM Biologics announced today that Dr. Bram Bout, VP Protein Production of Crucell, will present new PER.C6(TM) productivity and scalability data at the upcoming Biophex conference.
Dr. Bout's presentation underscores the progress made in the Crucell - DSM Biologics alliance, which has successfully met predetermined R&D milestones.
The Biophex conference will be held from September 23-25, 2003, at the San Jose McEnery Convention Center in San Jose, California. The conference highlights innovative solutions to the challenges of biopharmaceutical development and production. Dr. Bout's presentation will take place on Thursday, September 25, 2003, at 8:00 a.m. Pacific Time.
Dr. Bout's presentation will focus on PER.C6(TM) for the production of monoclonal antibodies, including the safety of the PER.C6(TM) cell line and the high quantity and quality of the material produced using this unique platform technology. Following the conference, key slides of Dr. Bout's presentation will be available on the Crucell website, www.crucell.com.